Evaluate the Safety and Tolerability of JCXH-212 Monotherapy and Combined With Toripalimab in the Treatment of Malignant Solid Tumors
Clinical trial NCT05579275 · RECRUITING
Trial details
- NCT number
- NCT05579275
- Sponsor
- Peking University Cancer Hospital & Institute
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-06
- Primary completion
- 2026-04-28
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.